Jorge Sánchez‐Guerrero

27.1k total citations · 3 hit papers
87 papers, 7.0k citations indexed

About

Jorge Sánchez‐Guerrero is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Jorge Sánchez‐Guerrero has authored 87 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Rheumatology, 23 papers in Pathology and Forensic Medicine and 22 papers in Immunology. Recurrent topics in Jorge Sánchez‐Guerrero's work include Systemic Lupus Erythematosus Research (57 papers), Systemic Sclerosis and Related Diseases (16 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Jorge Sánchez‐Guerrero is often cited by papers focused on Systemic Lupus Erythematosus Research (57 papers), Systemic Sclerosis and Related Diseases (16 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Jorge Sánchez‐Guerrero collaborates with scholars based in Mexico, United States and Canada. Jorge Sánchez‐Guerrero's co-authors include D Alarcón-Segovia, Richard Furie, Ellen M. Ginzler, Michelle Petri, Matthew H. Liang, Gerald B. Appel, Javier Cabiedes, William W. Freimuth, Douglas R. Hough and Z. John Zhong and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Jorge Sánchez‐Guerrero

80 papers receiving 6.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

2011 1.1k citations Michelle Petri, Ricard Cervera et al. Arthritis & Rheumatism profile →
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

2012 972 citations Brad H. Rovin, Jorge Sánchez‐Guerrero et al. Arthritis & Rheumatism profile →
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with Systemic Lupus Erythematosus

1997 587 citations Dafna D. Gladman, Paul R. Fortin et al. Arthritis & Rheumatism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jorge Sánchez‐Guerrero Mexico	34	5.3k	3.0k	1.7k	996	735	87	7.0k
Dominique Ibañez Canada	37	5.5k 1.0×	3.5k 1.2×	1.3k 0.7×	928 0.9×	586 0.8×	79	6.6k
Rosalind Ramsey‐Goldman United States	51	5.7k 1.1×	3.8k 1.3×	1.4k 0.8×	1.5k 1.5×	580 0.8×	208	8.4k
Chi Chiu Mok China	55	6.3k 1.2×	3.5k 1.2×	1.3k 0.7×	990 1.0×	1.5k 2.0×	228	8.3k
Alessandro Mathieu Italy	35	4.3k 0.8×	2.3k 0.8×	845 0.5×	1.0k 1.0×	409 0.6×	143	5.8k
Kenneth Kalunian United States	46	6.5k 1.2×	4.5k 1.5×	2.4k 1.4×	799 0.8×	388 0.5×	156	8.2k
Susan Manzi United States	45	5.1k 0.9×	3.9k 1.3×	1.2k 0.7×	667 0.7×	459 0.6×	118	6.8k
Elisabet Svenungsson Sweden	46	4.8k 0.9×	3.9k 1.3×	856 0.5×	765 0.8×	525 0.7×	193	7.2k
Barri J. Fessler United States	39	3.7k 0.7×	2.3k 0.8×	680 0.4×	979 1.0×	411 0.6×	63	5.4k
M Ingelmo Spain	54	6.4k 1.2×	2.4k 0.8×	1.0k 0.6×	1.2k 1.2×	1.0k 1.4×	158	9.2k
Ellen M. Ginzler United States	44	7.9k 1.5×	4.6k 1.5×	2.9k 1.7×	1.1k 1.1×	2.0k 2.8×	98	9.5k

Countries citing papers authored by Jorge Sánchez‐Guerrero

Since Specialization

Citations

This map shows the geographic impact of Jorge Sánchez‐Guerrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Sánchez‐Guerrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Sánchez‐Guerrero more than expected).

Fields of papers citing papers by Jorge Sánchez‐Guerrero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Sánchez‐Guerrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Sánchez‐Guerrero. The network helps show where Jorge Sánchez‐Guerrero may publish in the future.

Co-authorship network of co-authors of Jorge Sánchez‐Guerrero

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Sánchez‐Guerrero. A scholar is included among the top collaborators of Jorge Sánchez‐Guerrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Sánchez‐Guerrero. Jorge Sánchez‐Guerrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parodis, Ioannis, Valeria Albertón, Hans‐Joachim Anders, et al.. (2025). Lupus nephritis trials network (LNTN) repeat kidney biopsy-based definitions of treatment response: A systematic literature review-based proposal. Autoimmunity Reviews. 24(7). 103810–103810. 1 indexed citations

Manzi, Susan, Jorge Sánchez‐Guerrero, Naoto Yokogawa, et al.. (2025). The effect of belimumab on mucocutaneous and vasculitis manifestations in patients with systemic lupus erythematosus: A large pooled post hoc analysis. Lupus. 34(7). 666–678.

Almaani, Salem, Udayan Bhatt, Cristina Arriens, et al.. (2020). Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints. Kidney International Reports. 5(8). 1302–1305.

Johnson, Sindhu R., Dinesh Khanna, David Daikh, et al.. (2018). Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria. The Journal of Rheumatology. 46(7). 721–726. 30 indexed citations

Hinojosa‐Azaola, Andrea, et al.. (2016). Venous and Arterial Thrombotic Events in Systemic Lupus Erythematosus. The Journal of Rheumatology. 43(3). 576–586. 29 indexed citations

Hernández‐Molina, Gabriela, Gilberto Vargas‐Alarcón, José Manuel Rodrı́guez-Pérez, et al.. (2014). High-resolution HLA analysis of primary and secondary Sjögren’s syndrome: a common immunogenetic background in Mexican patients. Rheumatology International. 35(4). 643–649. 7 indexed citations

Petri, Michelle, Caroline Gordon, JT Merrill, et al.. (2011). Derivation and Validation of Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus. Carolina Digital Repository (University of North Carolina at Chapel Hill). 1 indexed citations

Faust, Thomas W., Eric H. Chang, Czeslawa Kowal, et al.. (2010). Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proceedings of the National Academy of Sciences. 107(43). 18569–18574. 161 indexed citations

Cesarman‐Maus, Gabriela, et al.. (2010). Autoantibodies Against the Fibrinolytic Receptor, Annexin A2, in Cerebral Venous Thrombosis. Stroke. 42(2). 501–503. 26 indexed citations

10.

Hernández‐Molina, Gabriela, et al.. (2010). Similarities and Differences Between Primary and Secondary Sjögren’s Syndrome. The Journal of Rheumatology. 37(4). 800–808. 41 indexed citations

11.

Romero‐Díaz, Juanita, et al.. (2008). Thrombosis in Systemic Lupus Erythematosus and Other Autoimmune Diseases of Recent Onset. The Journal of Rheumatology. 36(1). 68–75. 52 indexed citations

12.

Martı́nez-Baños, Déborah, José C. Crispín, Alejandro Lazo‐Langner, & Jorge Sánchez‐Guerrero. (2006). Moderate and severe neutropenia in patients with systemic lupus erythematosus. Lara D. Veeken. 45(8). 994–998. 39 indexed citations

13.

Sánchez‐Guerrero, Jorge, et al.. (2005). A Trial of Contraceptive Methods in Women with Systemic Lupus Erythematosus. New England Journal of Medicine. 353(24). 2539–2549. 180 indexed citations

14.

Karlson, Elizabeth W., Susan E. Hankinson, Matthew H. Liang, et al.. (1999). Association of silicone breast implants with immunologic abnormalities: a prospective study. The American Journal of Medicine. 106(1). 11–19. 43 indexed citations

15.

Sánchez‐Guerrero, Jorge, Robert Lew, Anne H. Fossel, & Peter H. Schur. (1996). Utility of anti‐Sm, anti‐RNP, anti–Ro/SS‐A, and anti–La/SS‐B (extractable nuclear antigens) detected by enzyme‐linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Arthritis & Rheumatism. 39(6). 1055–1061. 55 indexed citations

16.

Cabral, Antonio R., Javier Cabiedes, D Alarcón-Segovia, & Jorge Sánchez‐Guerrero. (1992). Phospholipid specificity and requirement of β2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome. Journal of Autoimmunity. 5(6). 787–801. 27 indexed citations

17.

Sánchez‐Guerrero, Jorge, et al.. (1990). Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature.. PubMed. 17(11). 1458–62. 115 indexed citations

18.

Lavalle, C, et al.. (1990). Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies.. PubMed. 17(1). 34–7. 139 indexed citations

19.

Sánchez‐Guerrero, Jorge & D Alarcón-Segovia. (1990). SALMONELLA PERICARDITIS WITH TAMPONADE IN SYSTEMIC LUPUS ERYTHEMATOSUS. Lara D. Veeken. 29(1). 69–71. 26 indexed citations

20.

Alarcón-Segovia, D, et al.. (1989). Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients. Medicine. 68(6). 353–365. 482 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact